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Recently, an innovative gluten detoxification method called Gluten FriendlyTM (GF) has
been developed. It induces structural modifications, which abolish the antigenic capacity
of gluten and reduce the in vitro immunogenicity of the most common epitopes involved
in celiac disease, without compromising the nutritional and technological properties. This
study investigated the in vitro effects of GF bread (GFB) on the fecal microbiota from
healthy and celiac individuals by a three-stage continuous fermentative system, which
simulates the colon (vessel 1, proximal colon; vessel 2, transverse colon; and vessel
3, distal colon), as well as on the production of short chain fatty acids (SCFA, acetate,
propionate, butyrate). The system was fed with GFB and the changes in microbiota
through fluorescence in situ hybridization and in SCFA content were assessed. GFB
exerted beneficial modulations such as bifidogenic effects in each compartment of the
model both with healthy- and celiac-derived samples, as well as growth in Clostridium
clusters XIVa+b in celiac-derived samples. Furthermore, increased levels of acetic acid
were found in vessel 1 inoculated with the fecal microbiota of healthy individuals, as well
as acetic and propionic in vessel 1 and 2 with celiac-derived samples. In addition, the
use of multivariate approaches showed that the supplementation of GFB could result in a
different modulation of the fecal microbiota and SCFA, as a function of initial equilibrium.
Keywords: Gluten Friendly bread, fecal microbiota, celiac, healthy, gut model
INTRODUCTION
The composition and the metabolism of human microbiota play crucial roles in human
health. Microbial colonization of the gastrointestinal tract varies widely, with the large
intestine having not only the highest density of microbes in terms of bacterial cells per
gram but also the most metabolically active organ (Turnbaugh et al., 2006). Genetics, mode
of birth, infant feeding patterns, antibiotic usage, sanitary living conditions, and long-term
dietary habits contribute to shaping the composition of the gut microbiome. Diet clearly
has been considered as a major driver for changes in the compositional and functional
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relationship between microbiota and the host (Muegge et al.,
2011). The fermentative but also (anaerobic) respiratory bacterial
metabolism of dietary components produces an extraordinary
chemical diversity in the large intestine with protective (e.g., short
chain fatty acids [SCFAs]) or detrimental (e.g., hydrogen sulfite,
phenol, p-cresol, or bile acids) e ects on the disease development
(Flint, 2012). There have been numerous attempts to identify
a “core” microbiota, usually defined as bacterial taxa that are
shared between 95% of individuals tested. Identification of a core
microbiome is important for defining a “normal” healthy state
from which major variations may indicate a dysbiotic system that
can result from or contribute to disease development.
Recent reports have shown how the intestinal microbiota
in celiac patients might be altered and influenced underlying
mucosal immune response. Celiac disease (CD) is a chronic
immune-mediated enteropathy triggered by the ingestion
of gluten, the water-insoluble protein fraction in wheat,
rye, and barley, in patients who are HLA-DQ2 or HLA-
DQ8 positive. Approximately 30% of the general population
carry the HLA-DQ2/8 CD susceptibility genes; however,
only 2–5% of these individuals will go on to develop CD,
suggesting that additional environmental factors contribute
to disease development. Generally, gluten-free diet alleviates
many of the symptoms, but somewhat surprisingly, it does not
completely restore healthy microbiota profiles (Wacklin et al.,
2014).
Recently, a new and innovative gluten detoxification method
has been developed (PCT/IB2013/000797) (Lamacchia et al.,
2013, 2015a). It is usually referred to as Gluten FriendlyTM
(GF) and lies in the application of microwave energy for
few seconds to hydrated wheat kernels. This technology
induces structural modifications to endosperm components
which abolish the antigenic capacity of gluten and dramatically
reduce in vitro the immunogenicity of the most common
epitopes involved in CD (Lamacchia et al., 2015b, 2016),
without compromising both the nutritional and technological
properties necessary to process flour into bread, pasta, and
other baked goods. Recently, Landriscina et al. (2017) confirmed
the e ect of this new technology on the immunogenic
epitopes. They combined microscopy with immunodetection
with specific antibodies for gliadins, g-gliadins, LMW subunits,
and antigenic epitopes to gain a better understanding of
the technology at a molecular level. Cross-reactivity toward
the antibodies recognizing almost the entire range of gluten
proteins as well as the antigenic epitopes through the sequences
QQSF, QQSY, PEQPFPQGC, and QQPFP was significantly
reduced.
This study aimed to investigate the impact of the
administration of GF bread (GFB) on the fecal microbiota
of healthy and celiac volunteers using a three-stage continuous
culture colonic model system. This is a useful tool to monitor
the ecology and metabolic activities of the microbiota in the
proximal, transverse, and distal colon, in relation to di erent
environmental conditions, dietary intervention, and the
administration of drugs and antimicrobials. The influence of
GFB on the fecal microflora and SCFA production [acetate,
propionate (PRO), butyrate] was determined.
MATERIALS AND METHODS
Substrate
Grain of treated wheat (according to the patented method PCT
n. PCT/IB2013/000797) was milled commercially and kindly
supplied by Casillo Group S.p.A1. The treatment was performed
as follows: 100 g of cleaned wheat grains was dampened until
reaching 15–18% humidity, which was measured by a halogen
thermal balance (Mettler Toledo, HB43-S, Switzerland), and
subjected to rapid heating via microwaves (Delonghi, Italy;
approximately 1 min between 1000 and 750 watts), followed by
slow evaporation of the water. The rapid heating and subsequent
slow evaporation of the water was repeated until reaching a
final temperature of 80–90 C, which was measured by a thermal
camera (Fluke, i20 Model, Italy), and a moisture degree of 13–
13.5% in the wheat grains.
After microwave treatment, the wheat kernels were cooled and
dried at room temperature (24 C) for 12–24 h and then ground
using an automatic laboratory mill MCKA (Bühler AG, Uzwil,
Switzerland; diameter of grid 118–180 µm) (Bevilacqua et al.,
2016).
Gluten Friendly bread was prepared according to the bread-
making process (100 g wheat flour, 66 mL water, 1.33 g yeast, 1 g
salt) to the Chorleywood Bread Process (Bevilacqua et al., 2016).
Simulated In Vitro Human Digestion
Prior to being added to the in vitro colonic system, GFB was
digested in vitro, under appropriate conditions according to the
procedures described byMaccaferri et al. (2012) to mimic mouth,
stomach, and intestine’s condition.
Fecal Samples Collection and Inocula
Preparation
Fecal samples were obtained from two healthy and two celiac
donors (male and female aged 30–50 years old) who were
free of any metabolic and gastrointestinal diseases, were not
taking probiotic or prebiotic supplements, and had not taken
antibiotics 6 months before fecal sample donation. All donors
have provided written informed consent and filled in a standard
questionnaire to collect information regarding health status, drug
use, clinical anamnesis, and lifestyle factors. The University of
Reading Research Ethics Committee (UREC 15/20) approved
this study in accordance with the Declaration of Helsinki.
Sample size was in accordance with previous studies (Bevilacqua
et al., 2016). Fecal samples were placed in an anaerobic jar
(AnaeroJarTM 2.5 L, Oxoid Ltd.) including a Gas-Generating Kit
(AnaeroGenTM, Oxoid Ltd.) in order to reproduce anaerobic
conditions inside the chamber. An aliquot of 20 g of samples
was diluted in 100 mL anaerobic PBS (0.1 mol/L phosphate
bu er solution, pH 7.4, w/w) and homogenized (Stomacher 400;
Seward, West Sussex, UK) for 2 min at 240 paddle beats per
minute. Samples were added to anaerobic fermenters within
15 min of voiding.
1http://www.casillogroup.com/en/home-eng.html
Frontiers in Microbiology | www.frontiersin.org 2 September 2017 | Volume 8 | Article 1722
fmicb-08-01722 September 6, 2017 Time: 16:59 # 3
Costabile et al. Gluten Friendly and Fecal Microbiota
Three Stage-Continuous Culture Gut
Model System
Physicochemical conditions in the colon were replicated in
a three-stage continuous system, comprised of a cascade of
three glass fermenters of increasing working volume connected
in series. A small-scale version of the validated system by
Macfarlane et al. (1998) has been used in this study, as suggested
by Grimaldi et al. (2017). The gut model is often used to resemble
the complexity and diversity of the intestinal microbiota and
simulates the proximal [vessel 1 (V1), 80 mL, pH 5.5], transverse
[vessel 2 (V2), 100 mL, pH 6.2], and distal colon [vessel 3 (V3),
120 mL, pH 6.8] (Figure 1); the vessels were filled with fecal
homogenate from healthy and celiac volunteers (20%) and a
complex colonic growth medium (80%). The growth medium
contained the following ingredients: starch, 5 g/L; mucin, 4 g/L;
casein, 3 g/L; peptone water, 5 g/L; tryptone water, 5 g/L; bile
salts, 0.4 g/L; yeast exact, 4.5 g/L; FeSO4, 0.005 g/L; NaCl,
4.5 g/L; KCl, 4.5 g/L; KH2PO4, 0.5 g/L; MgSO4 ⇥ 7H2O,
1.25 g/L; CaCl2 ⇥ 6H2O, 0.15 g/L; NaHCO3, 1.5 g/L;
Tween 80, 1 mL; hemin, 0.05 g/L; and cysteine HCl, 0.8 g/L.
Following inoculation, the colonic model was run as a batch
culture for 24 h to stabilize the bacterial populations prior to
the initiation of medium flow. After 24 h (T0), the medium
flow was initiated and the system was ran for eight full volume
turnovers to allow for steady state to be achieved (SS1) assessed
through stabilization of the SCFA profiles (±5%); the duration
of each turnover was 48 h, thus this first step was done for
384 h. The flow rate of the system was 6.25 mL/h. The system
was run for further eight volume turnovers upon which steady-
state 2 (SS2) was achieved; daily 3.75 mL of digested GFB was
added. Each steady state was confirmed by stabilization of SCFAs
profiles over 3 consecutive days. SS2 was achieved after 384 h;
the whole experiments took place for 792 h. Each vessel was
magnetically stirred and continually sparged with oxygen free
nitrogen gas. Temperature (37 C) was maintained by a water-
cooling system and culture pH was controlled automatically
through the addition of 1 N NaOH or HCl. Aliquots of 4.5 mL
were removed at SS1 and SS2 from each vessel (V1, V2,
and V3).
Short Chain Fatty Acids (SCFAs) Analysis
by HPLC
The production of acetic, propionic, and butyric acids in
the fermentations was determined by HPLC (Merck, NJ,
United States) equipped with RI detection. The column used
was an ion-exclusion REZEX-ROA organic acid column
(Phenomenex Inc., United Kingdom) and temperature
maintained at 84 C. Sulfuric acid in HPLC-grade H2O
(0.0025 mmol/L) was used as the eluent, and the flow rate
was maintained at 0.5 mL/min. Aliquots of 1 mL collected from
each vessel in microcentrifuge tubes were centrifuged at 1136⇥ g
for 10 min to remove all particulate matter. The supernatants
were then filtered using 0.22 µm low protein binding Durapore
polyvinylidene fluoride (PVDF) membranes (Millex; EMD
Millipore, Billerica, MA, United States). Twenty microliters
of each sample was injected with a run of 45 min. Peaks were
integrated using the Atlas Lab Managing Software (Thermo
Lab Systems, Mainz, Germany). Quantification of the samples
was obtained through calibration curves of acetic, propionic,
and butyric acids in concentrations ranging between 12.5 and
100 mM.
In Vitro Enumeration of Bacterial
Populations by Fluorescence In Situ
Hybridization (FISH) Analysis
Fluorescence in situ hybridization analysis was performed as
described by Costabile et al. (2014). Briefly, aliquots (375 µL)
of gut model samples were fixed in three volumes of ice-
cold 4% (w/v) paraformaldehyde for 4 h at 4 C. They were
then centrifuged at 13,000 ⇥ g for 5 min and washed twice
in 1 mL of sterile PBS. The cells were again pelleted by
centrifugation and re-suspended in 150 µL of sterile PBS, to
which 150 µL of ethanol was added. Samples were then vortexed
and stored at  20 C until used in hybridizations. For the
hybridizations, all probes were commercially synthesized and 50-
labeled with the fluorescent dye (Sigma-Aldrich, St. Louis, MO,
United States). The probes used in this study are detailed in
Table 1.
Statistical Analysis
The analyses were performed on two independent batches
(two healthy donors and two celiac subjects); for each
batch, the experiments were done in triplicate. Bacterial
counts and SCFAs were statistically analyzed using paired
t-tests to assess the e ect of the same treatment at
di erent time points. Significant di erences were defined
at p < 0.05. All analyses were performed using GraphPad
Prism 6.0.
Furthermore, FISH and SCFAs data were standardized and
reported as increase/decrease of SS2 (steady state at the end of
the assay) relative to SS1 (steady state before the addition of GFB);
each donor was treated as a separate “sample.”
First, a principal component analysis was run by using all
SCFA and microbial groups as leading variables. The analysis was
done following the traditional approach of PCA to qualitatively
study the e ect of the supplementation of GFB on each donor in
each vessel.
Thereafter, the PCA was modified and run through the
approach of the Multivariate Statistical Process Control/NIPALS
algorithm (non-linear iterative partial least square); the number
of interactions was set to 50. For this second analysis, the
leading variables were either standardized SCFA or standardized
microbial counts. The main outputs of this second approach
are the standardized plots, showing the cases (i.e., each donor
per each vessel), the line of the leading variables (the microbial
groups for the first analysis and the SCFAs for the second
analysis) and for each variable the minimum and maximum
values. The benefit of this approach is that it allows the reader
to point out both a qualitatively and a quantitatively grouping
of cases. PCA and modified PCA were done through the
software Statistica for Windows, ver. 12.0 (Statsoft, Tulsa, OK,
United States).
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FIGURE 1 | Schematic chart of gut model system used in this research.
TABLE 1 | FISH oligonucleotide probes used in this study.
Probe Target bacterial group/species Target sequence (50–30) Hybridization/washing T ( C) Reference
Bifl64 Bifidobacterium spp. (BIF) CATCCGGCATTACCACCC 50–50 Langendijk et al., 1995
Erec482 Clostridium clusters XIVa+b (ERE) GCTTCTTAGTCARGTACCG 50–50 Franks et al., 1998
Labl58 Lactobacillus/Enterococcus spp. (LAB) GGTATTAGCAYCTGTTTCCA 50–50 Harmsen et al., 1999
Chisl50 Clostridium histolyticum group clusters I, II (CHI) TTATGCGGTATTAATCTYCCTTT 50–50 Franks et al., 1998
Bac303 Bacteroides–Prevotella group (BAC) CCAATGTGGGGGACCTT 46–48 Manz et al., 1996
Eub338 I⇤ Most bacteria (EUB) GCTGCCTCCCGTAGGAGT 46–48 Daims et al., 1999
Eub338 II⇤ Most bacteria (EUB) GCAGCCACCCGTAGGTGT 46–48 Daims et al., 1999
Eub338 III⇤ Most bacteria (EUB) GCTGCCACCCGTAGGTGT 46–48 Daims et al., 1999
⇤These probes were used in equimolar concentrations (50 ng/mL). Formamide (35%) was included in the hybridization buffer.
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RESULTS
Bacterial Enumeration and SCFA
Changes in the bacterial composition are in Figure 2; these
results focused on the global e ect of GFB, without considering
a possible variability linked to donors. A significant increase in
numbers of bacteria within the Bifidobacterium genus was found;
fecal microbiota of celiac donors showed a significant increase
in this population from 8.42 to 8.90 log CFU/mL (p < 0.05)
and from 8.60 to 9.20 log CFU/mL (p < 0.05) in V2 and V3,
respectively, transverse and distal colon. In the fecal samples of
healthy volunteers, there was a significant increase in numbers
of bifidobacteria (BIF) in V3, from 7.90 to 8.40 log CFU/mL
(p < 0.05). Significant increases were also found in numbers of
bacteria in all vessels for celiac volunteers in Clostridium cluster
population, from 8.85 to 9.50 (V1), from 9.1 to 9.60 (V2), and
from 9.00 to 9.50 log CFU/mL (V3) (p< 0.05) (ERE).
The results of SCFAs are in Figure 3. The fermentation of
GFB by the fecal microbiota of healthy donors showed significant
di erences of acetic acid in all vessels, from 28.80 to 22.10 (V1)
(p< 0.01), from 44.40 to 56.94 (V2) (p< 0.01), and from 46.00 to
76.50 mM (V3) (p< 0.001), respectively; butyrate also increased.
Regarding the fecal microbiota of celiac volunteers, significant
increases of propionic production were found in V1 andV2, from
45.10 to 69.20 (p< 0.01) and from 50.80 to 70.20 mM (p< 0.05),
respectively; also, acetic acid showed a significant increase in V1,
from 41.20 to 89.00 mM (p< 0.01).
Multivariate Approach
The last approach was a focus on the multivariate di erences
induced by the supplementation of GFB. The results were
reported as increase/decrease in FISH, and SCFAs (di erence
SS2 SS1). Figure 4 shows the Principal Component Analysis
on FISH and SCFA variations; all acids and microbial counts
were used as leading variables. A di erence from the previous
approach (Figures 2, 3) was the use of each donor as a
separate sample to highlight the di erences due to the di erent
fecal microbiota (e ect of “donor”). Figure 4A shows the
projection of the leading variables. Bifidobacteria (BIF) and
Bacteroides/Prevotella (BAC) were mostly related to the factor 2
(the correlation coe cients were 0.918 and 0.874, respectively),
whereas Lactobacillus/Enterococcus (LAB), Clostridium (EREC),
and propionate (PRO) were related to the factor 1 (correlation
coe cients ranging from 0.804 to 0.934). This first PCA suggests
an e ect of GFB on the whole ecosystem (fecal microbiota and
produced acids); however, this e ect could be also a ected by the
initial situation of the system, in this analysis expressed as “the
donor.” GFB exerted a strong e ect on the fecal microbiota of
the celiac donor 2, as suggested by the shift from c2–v1 (acids
and fecal microbiota of the celiac donor 2 in the first vessel)
to c2–v2 and c2–v3. The increase of BIF played a major role
for this increase. On the other hand, the same e ect was not
found in the vessels inoculated with the fecal microbiota of the
celiac donor 1. A modification of the system was also found
in the vessels inoculated with the fecal microbiota of healthy
donor 1, as a slight shift toward right was found (from v1 to
v2–v3).
This first approach suggests that GFB could induce a shift
and a modification of the ecosystem; however, due to the high
number of the leading variables (nine), the accounted variability
explained by the statistic is quite low (ca. 57%). Therefore, a
second approach was used by using either the data of FISH and on
SCFA; in addition, PCA was modified with NIPALS algorithm to
achieve quantitative data for each vessel and see what is the e ect
of the supplementation on the evolution from V1 to V2 and V3
and simulate what could happen from a region to another of the
colon.
Figure 5A shows the results for the FISH. In the
fecal microbiota of the healthy donor 1, the e ect of the
supplementation could be seen in the vessel 1, without
FIGURE 2 | Bacterial groups in the culture broth recovered from the three different vessels (V1, V2, and V3) of the colonic model system before (SS1) and after (SS2)
GFB supplementation. Inoculation with fecal slurries from healthy (A) and celiac donors (B). Results are reported as means of the data of two models ± SEM (n = 2).
SS1, steady state 1; SS2, steady state 2; GFB, Gluten Friendly bread; LAB, Lactobacillus–Enterococcus (Lab158); BIF, bifidobacteria (Bif164); BAC,
Bacteroides–Prevotella (Bac303); ERE, Clostridium clusters XIVa+b (Erec482); CHI, Clostridium group clusters I, II (Chis 150); and EUB, bacteria (Eub 338 I, 338 II,
338 III).
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FIGURE 3 | SCFA concentrations in the culture broths recovered from the three different vessels (V1, V2, and V3) of the colonic model system before (SS1) and after
(SS2) GFB supplementation. Inoculation with fecal slurries from healthy (A) and celiac donors (B). Results are reported as means of the data of two models ± SEM
(n = 2). SS1, steady state 1; SS2, steady state 2; GFB, Gluten Friendly bread.
FIGURE 4 | Principal Component Analysis on the increase of FISH counts and SCFA after the supplementation of GFB; the gut models were inoculated with the
fecal slurries from healthy (letter H) and celiac donors (letter C). V1, V2, and V3, vessels of the colonic model and 1 and 2, donors 1 or donors 2; LAB,
Lactobacillus–Enterococcus (Lab158); BIF, bifidobacteria (Bif164); BAC, Bacteroides–Prevotella (Bac303); ERE, Clostridium clusters XIVa+b (Erec482); CHI,
Clostridium group clusters I, II (Chis 150); EUB, bacteria (Eub 338 I, 338 II, 338 III); BUT, butyrate; ACE, acetate; and PRO, propionate. (A) The projection of the
variables, whereas (B) reports case projection.
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FIGURE 5 | Principal Component Analysis on the increase of FISH counts and SCFA after the supplementation of GFB; the gut models were inoculated with the
fecal slurries from healthy (letter H) and celiac donors (letter C). V1, V2, and V3, vessels of the colonic model; 1 and 2, donors 1 or donors 2. The numbers on the
projection of the leading variables represent the quantitative data (minimum, central point, or maximum). (A) Effect on FISH counts. LAB, Lactobacillus–Enterococcus
(Lab158); BIF, bifidobacteria (Bif164); BAC, Bacteroides–Prevotella (Bac303); ERE, Clostridium clusters XIVa+b (Erec482); CHI, Clostridium group clusters I, II (Chis
150); and EUB, bacteria (Eub 338 I, 338 II, 338 III). (B) Effect on SCFA. BUT, butyrate; ACE, acetate; PRO, propionate. (A) The projection of the variables, whereas
(B) reports case projection.
di erences from the vessels 2 and 3. On the other hand, the fecal
microbiota of the healthy donor 2 experienced some di erences,
as from V1 to V2–V3 there was an e ect on BIF, with a slight
increase (ca. 0.4 log CFU/mL).
The most important di erences were found for the fecal
microbiota of the celiac donors: in the donor 2, there was a shift
from vessel 1 to vessels 2 and 3, probably due to BIF. In the
vessel 1, there was a decrease of BIF (ca. 1 log CFU/mL), while
in the vessels 2 and 3 BIF were restored with a mean decrease of
0.0–0.2 log CFU/mL.
The e ect on the fecal microbiota of the celiac donor 1
was di erent. A slight e ect on BIF was found in the
vessel 1 and maintained in the vessels 2 and 3 (0.5–0.8 log
CFU/mL), but a shift was found due to the di erent e ect on
Lactobacillus/Enterococcus and Clostridium cluster XIVa+b, as in
the vessel 1 the increase was not significant (0.2 log CFU/mL),
but in the vessel 3 the mean increase was 0.6–0.8 log CFU/mL.
The di erence in lactobacilli population was not significant when
the mean between the two donors was done; on the other hand, a
preliminary t-test revealed that on the donor 1 it was significant
(p< 0.01).
Figure 5B shows the NIPALS approach for the SCFA; the
main di erence was in c2–v2 (vessel 2 inoculated with the fecal
microbiota of the celiac donor 2). In this vessel, there was a strong
increase of butyrate (ca. 45–50 mmol/L).
DISCUSSION
The human colon contains a wide range of bacterial
communities, distributed in hundreds of distinct species,
and the balance among them plays an important role in
health and disease (Holzapfel et al., 1998; Rigottier-Gois et al.,
2003). Although a consensus for what constitutes a core gut
microbiome has been elusive, one report suggested that an
international cohort of 39 individuals could be assigned to one
of three distinct clusters or “enterotypes” based on metagenomic
sequences. Arumugam et al. (2011) have found that each cluster
was dominated by a particular bacterial genus (Bacteroides,
Prevotella, and Ruminococcus) with positive or negative
associations with a number of other genera in the community.
Many authors have found di erences in the composition of
the intestinal microbiota between CD patients and healthy
volunteers (Collado et al., 2007; Sanz et al., 2007; Di Cagno
et al., 2009; De Palma et al., 2010; Nistal et al., 2012; Sellitto
et al., 2012). In fact, CD patients frequently present altered
intestinal bacterial groups such as Bifidobacterium, Lactobacillus,
Bacteroides, Prevotella, Staphylococcus, and Escherichia (Collado
et al., 2007; Sanz et al., 2007; De Palma et al., 2010; Iebba et al.,
2011; Sellitto et al., 2012). Mainly, a reduction in Bifidobacterium
population diversity in CD patients was also found (Sanz et al.,
2007; Collado et al., 2008), along with an increase of Bacteroides
and Clostridium leptum groups (Collado et al., 2008).
Gluten exerts negative e ects in terms of immunological
response in CD; moreover, there are some evidences on possible
changes induced on the colonmicrobiota. Bevilacqua et al. (2016)
used the batch cultures approach to study the e ect of the
supplementation of either control or GFB on the microbiota of
healthy and celiac volunteers. They found that the addition of
control bread to the batches containing the microbiota of celiac
volunteers determined a strong and significant decrease of BIF.
On the other hand, the supplementation of GFB induced a partial
restoration of BIF and lactobacilli, with a change of the whole
system (microbiota+SCFA). These results were found within
48 h; thus, in the present study stool samples were collected
from celiac and healthy volunteers, in order to better understand
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the di erences in microbiota composition and metabolic activity
induced by GFB after a prolonged supplementation and in a
system able to simulate the whole colon.
Significant increases in bifidobacterial numbers were observed
in response to GFB in the fecal microbiota of healthy and celiac
donors. BIF are recognized as one of the most important bacterial
groups associated with human health, providing beneficial e ects
in the large intestine (Gibson andWang, 1994; Russel et al., 2011);
the positive e ect on bifidobacterial, as well as the slight e ect
on the lactic acid bacteria in the fecal microbiota of the celiac
donors 1, confirmed previous results (Bevilacqua et al., 2016).
The positive e ect of GFB on some bacteria could be
attributed to the changes in the secondary and the tertiary
structures of the proteins, as suggested by SDS page, the
increase in cysteine amounts, and protein aggregation at SEM
(Lamacchia et al., 2016; Landriscina et al., 2017). These changes
could be responsible of the reduction of the cross-reactivity
toward some antibodies (Landriscina et al., 2017), as well
as on a di erent exposition and arrangement of charges, as
postulated previously (Bevilacqua et al., 2016). This di erent
arrangement of charges could be the primary factor leading
to a positive e ect on some Gram-positive bacteria, like
BIF.
The GFB fermentation also increased Clostridium cluster
XIVa. This cluster contains saccharolytic species which can
produce large concentrations of beneficial SCFAs from sugars,
such as butyrate. Clostridial clusters IV and XIVa have gained a
lot of attention during the last years because of their contribution
to gut homeostasis, by preserving gut barrier functions and
exerting immunomodulatory and anti-inflammatory properties
(Velasquez-Mano , 2015). In addition, some species of the
cluster, like Faecalibacterium prausnitzii, could produce anti-
inflammatory peptides (Quévrain et al., 2016).
The SCFAs produced by gut microbiota in the colon have
an important role. Butyric acid is often associated as an energy
source for the epithelial cells and acetic acid plays an important
role in controlling inflammation and controlling pathogen
invasion (Russel et al., 2013). In addition, other e ects attributed
to butyrate are the improvement of the gut barrier function by
stimulation of the formation of mucin, antimicrobial peptides,
and tight-junction proteins, the interaction with the immune
system and the reduction of the oxidative stress in the colon
(Rivière et al., 2016). Therefore, the increase of butyrate found
in the vessel 2 inoculated with the microbiota of a celiac
donor could be of interest and deserves further e orts and
experiments.
Moreover, the increase of acetic and propionic acids is
interesting as they also act as anti-inflammatory compounds,
could play a role in the stimulation of the immune system,
and decrease the pH of the colon (indirect antimicrobial e ect)
(Rivière et al., 2016).
The multivariate approaches and the NIPALS algorithm also
suggest that the e ect of GFB could also rely on the initial
equilibrium of the fecal microbiota and the positive e ect could
result in a di erent modulation of the microorganisms and SCFA;
in the present study, in the fecal microbiota of a celiac donor a
pronounced e ect on BIF was found, while the fecal microbiota
of the other celiac donor experienced a significant e ect on
Lactobacillus/Enterococcus.
In conclusion, this in vitro work provides encouraging
findings supporting the utilization of GF products with a positive
e ect on the fecal microbiota and SCFAs from celiac donors.
Generally, GFB induced increases in bifidobacterial counts and
a positive modulation of SCFAs, with an increase of butyrate,
acetate, and propionate. In addition, the use of multivariate
approaches showed that the supplementation of GFB could result
in a di erent modulation of the fecal microbiota and SCFA, as a
function of initial equilibrium of the microbiota.
The experiments were done on fecal slurries from two healthy
and two celiac donors, thus the results are as a kind of preliminary
evidence and should be confirmed and validated on a larger
number of samples and by an in vivo human intervention study.
However, the most important achievement of this paper is a
new horizon to be explored and studied: the possibility of the
modulation of colon microbiota by GFB.
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